These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32917127)

  • 21. Kynurenine and its metabolites in Alzheimer's disease patients.
    Gulaj E; Pawlak K; Bien B; Pawlak D
    Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of vitamin D in the association between pre-stroke sleep quality and poststroke depression and anxiety.
    Celikbilek A; Koysuren A; Konar NM
    Sleep Breath; 2024 May; 28(2):841-848. PubMed ID: 37542680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Symptoms of Depression and Anxiety One Year Poststroke: A Longitudinal Study.
    Kootker JA; van Mierlo ML; Hendriks JC; Sparidans J; Rasquin SM; de Kort PL; Visser-Meily JM; Geurts AC
    Arch Phys Med Rehabil; 2016 Jun; 97(6):919-28. PubMed ID: 26869287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.
    De Picker L; Fransen E; Coppens V; Timmers M; de Boer P; Oberacher H; Fuchs D; Verkerk R; Sabbe B; Morrens M
    Front Immunol; 2019; 10():2971. PubMed ID: 32010121
    [No Abstract]   [Full Text] [Related]  

  • 25. Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder.
    Tsuchiyagaito A; Smith JL; El-Sabbagh N; Zotev V; Misaki M; Al Zoubi O; Kent Teague T; Paulus MP; Bodurka J; Savitz J
    Neuroimage Clin; 2021; 29():102559. PubMed ID: 33516062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Anxiety and Depressive Symptoms in the Early Post-stroke Period.
    Todorov V; Dimitrova M; Todorova V; Mihaylova E
    Folia Med (Plovdiv); 2020 Dec; 62(4):695-702. PubMed ID: 33415913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine.
    Sun Y; Drevets W; Turecki G; Li QS
    Brain Behav Immun; 2020 Jul; 87():404-412. PubMed ID: 31978524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension.
    Jasiewicz M; Moniuszko M; Pawlak D; Knapp M; Rusak M; Kazimierczyk R; Musial WJ; Dabrowska M; Kaminski KA
    Heart; 2016 Feb; 102(3):230-7. PubMed ID: 26769378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
    Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
    Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study.
    Singh A; Black SE; Herrmann N; Leibovitch FS; Ebert PL; Lawrence J; Szalai JP
    Stroke; 2000 Mar; 31(3):637-44. PubMed ID: 10700497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Education Level Modulates the Presence of Poststroke Depression and Anxiety, But It Depends on Age.
    Samudio-Cruz MA; Toussaint-González P; Estrada-Cortés B; Martínez-Cortéz JA; Rodríguez-Barragán MA; Hernández-Arenas C; Quinzaños-Fresnedo J; Carrillo-Mora P
    J Nerv Ment Dis; 2023 Aug; 211(8):585-591. PubMed ID: 37184446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prolactin response to buspirone in poststroke depression: a preliminary report.
    Sevinçok L; Erol A
    J Affect Disord; 2000 Aug; 59(2):169-73. PubMed ID: 10837886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poststroke Depressive Symptoms Are Associated With Increased Oxidative Deoxyribonucleic Acid Damage.
    Chen CY; Chen CL; Yang YH; Ho CH; Tseng WC
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):139-144. PubMed ID: 29366374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessor- and participant-blinded, randomized controlled trial of dense cranial electroacupuncture stimulation plus body acupuncture for neuropsychiatric sequelae of stroke.
    Zhang ZJ; Zhao H; Jin GX; Man SC; Wang YS; Wang Y; Wang HR; Li MH; Yam LL; Qin ZS; Yu KT; Wu J; Ng FB; Ziea TE; Rong PJ
    Psychiatry Clin Neurosci; 2020 Mar; 74(3):183-190. PubMed ID: 31747095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe Periodontitis Is Associated with Early-Onset Poststroke Depression Status.
    Lin W; Xiong L; Yang Z; Deng X; Zhu J; Chen C; Huang S; Ma Y; Zhu F
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104413. PubMed ID: 31582272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
    Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
    J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder.
    Maget A; Platzer M; Bengesser SA; Fellendorf FT; Birner A; Queissner R; Hamm C; Reininghaus B; Hecker A; Tomberger L; Pilz R; Dalkner N; Moll N; Schütze G; Schwarz M; Kapfhammer HP; Reininghaus EZ
    Curr Top Med Chem; 2020; 20(15):1344-1352. PubMed ID: 31376822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.
    Karu N; McKercher C; Nichols DS; Davies N; Shellie RA; Hilder EF; Jose MD
    BMC Nephrol; 2016 Nov; 17(1):171. PubMed ID: 27832762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.